🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators are very excited that the National Institutes of Health a...
Status
Terminated
Location
Brigham and Women's Hospital- 221 Longwood Avenue
Start Date
1999-12
Trial ID
NCT01511042
Treatments Being Tested
The single patient (n-of-1) randomized trial is an underused approach to re...
Status
Completed
Location
The University of Texas Health Science Center at Houston
Start Date
2018-04-02
Trial ID
NCT03461003
Treatments Being Tested
In patients naive to treatment or after a 2-week washout period for patient...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00890591
Treatments Being Tested
This is a FIH, double-blind, placebo-controlled, within-group randomised, t...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2022-06-08
Trial ID
NCT05427253
Treatments Being Tested
This study is intended to investigate the effect of angiotensin receptor bl...
Status
Recruiting
Location
CRIUCPQ
Start Date
2020-02-01
Trial ID
NCT04913870
Treatments Being Tested
The renin angiotensin system (RAS) plays an important physiological and pat...
Status
Completed
Location
National Heart, Lung and Blood Institute (NHLBI)
Start Date
1997-07
Trial ID
NCT00001629
Treatments Being Tested
The aim of this study is to compare the short-term effects of ACEi and angi...
Status
Completed
Location
Yaounde Central Hospital, NAtional Obesity Center
Start Date
2017-12-20
Trial ID
NCT04222686
Treatments Being Tested
The study intervention focuses on exploring the use of angiotensin II as a ...
Status
Recruiting
Location
Deutsches Herzzentrum der Charité
Start Date
2025-03-31
Trial ID
NCT06615102
Treatments Being Tested
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-05-30
Trial ID
NCT05183646
Introduction: Heart Failure (HF) generates multiple hospital admissions and...
Status
Completed
Location
Hospital de usansolo-Galdakao
Start Date
2015-03
Trial ID
NCT02546856
Treatments Being Tested